228 related articles for article (PubMed ID: 32247208)
1. Impact of preexisting type 2 diabetes mellitus and antidiabetic drugs on all-cause and cause-specific mortality among Medicaid-insured women diagnosed with breast cancer.
Lawrence WR; Hosler AS; Gates Kuliszewski M; Leinung MC; Zhang X; Schymura MJ; Boscoe FP
Cancer Epidemiol; 2020 Jun; 66():101710. PubMed ID: 32247208
[TBL] [Abstract][Full Text] [Related]
2. Association between preexisting mental illnesses and mortality among medicaid-insured women diagnosed with breast cancer.
Lawrence WR; Kuliszewski MG; Hosler AS; Leinung MC; Zhang X; Zhang W; Du Z; Schymura MJ; Boscoe FP
Soc Sci Med; 2021 Feb; 270():113643. PubMed ID: 33387965
[TBL] [Abstract][Full Text] [Related]
3. Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes.
Tan E; Yang W; Pang B; Dai M; Loh FE; Hogan P
J Manag Care Spec Pharm; 2015 Dec; 21(12):1195-202. PubMed ID: 26679968
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus.
Gosmanova EO; Canada RB; Mangold TA; Rawls WN; Wall BM
Am J Med Sci; 2008 Sep; 336(3):241-7. PubMed ID: 18794619
[TBL] [Abstract][Full Text] [Related]
6. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
[TBL] [Abstract][Full Text] [Related]
7. Age-related differences in breast cancer mortality according to race/ethnicity, insurance, and socioeconomic status.
San Miguel Y; Gomez SL; Murphy JD; Schwab RB; McDaniels-Davidson C; Canchola AJ; Molinolo AA; Nodora JN; Martinez ME
BMC Cancer; 2020 Mar; 20(1):228. PubMed ID: 32178638
[TBL] [Abstract][Full Text] [Related]
8. The use of glucose-lowering medications for the treatment of type 2 diabetes mellitus during pregnancy in the United States.
Wood ME; Patorno E; Huybrechts KF; Bateman BT; Gray KJ; Seely EW; Vine S; Hernández-Díaz S
Endocrinol Diabetes Metab; 2022 Mar; 5(2):e00319. PubMed ID: 34953068
[TBL] [Abstract][Full Text] [Related]
9. Independent effects of 15 commonly prescribed drugs on all-cause mortality among US elderly patients with type 2 diabetes mellitus.
Baik SH; McDonald CJ
BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32341050
[TBL] [Abstract][Full Text] [Related]
10. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes.
Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Läärä E; Karihtala P; Jukkola A
Sci Rep; 2021 May; 11(1):10445. PubMed ID: 34001921
[TBL] [Abstract][Full Text] [Related]
11. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study.
Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Karihtala P; Jukkola A; Läärä E
Acta Oncol; 2020 Sep; 59(9):1110-1117. PubMed ID: 32478629
[No Abstract] [Full Text] [Related]
12. Associations between diabetes medication use and risk of second breast cancer events and mortality.
Calip GS; Yu O; Hoskins KF; Boudreau DM
Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
[TBL] [Abstract][Full Text] [Related]
13. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.
Häggström C; Van Hemelrijck M; Zethelius B; Robinson D; Grundmark B; Holmberg L; Gudbjörnsdottir S; Garmo H; Stattin P
Int J Cancer; 2017 Feb; 140(3):611-617. PubMed ID: 27770555
[TBL] [Abstract][Full Text] [Related]
15. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
[TBL] [Abstract][Full Text] [Related]
17. Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.
Xiao Y; Zhang S; Hou G; Zhang X; Hao X; Zhang J
Tumour Biol; 2014 Mar; 35(3):2035-45. PubMed ID: 24096546
[TBL] [Abstract][Full Text] [Related]
18. Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative.
Wang Z; Phillips LS; Rohan TE; Ho GYF; Shadyab AH; Bidulescu A; Rudick CN; Pan K; Chen Z; Luo J
Int J Cancer; 2023 Apr; 152(8):1556-1569. PubMed ID: 36444502
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data.
Bain S; Druyts E; Balijepalli C; Baxter CA; Currie CJ; Das R; Donnelly R; Khunti K; Langerman H; Leigh P; Siliman G; Thorlund K; Toor K; Vora J; Mills EJ
Diabetes Obes Metab; 2017 Mar; 19(3):329-335. PubMed ID: 27862902
[TBL] [Abstract][Full Text] [Related]
20. Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study.
Wong CKH; Man KKC; Shi M; Chan EW; Ho CW; Tse ETY; Wong ICK; Lam CLK
PLoS Med; 2019 Dec; 16(12):e1002999. PubMed ID: 31877127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
